Chau Q. Khuong

Biography

Chau joined OrbiMed Advisors in 2003 and is a Private Equity Partner focused on structured investments in private and public biopharmaceutical and medical device companies.  Mr. Khuong has been extensively involved with development and commercial stage companies in multiple therapeutic areas from cancer to anti-infectives to liver diseases and ophthalmology.  He is currently a Board Director or Observer at Aerpio, Cerapedics, Glaukos (NYSE: GKOS), Intercept Pharmaceuticals (NASDAQ: ICPT), Inspire Medical Systems, Intellia Therapeutics, Nabriva Pharmaceuticals, Otonomy (NASDAQ: OTIC), Pieris (NASDAQ: PIRS), Rempex, and Sonendo. Prior to OrbiMed, Mr. Khuong worked in start-up operations and business development at Veritas Medicine and also has experience in basic science research at Yale School of Medicine and Massachusetts General Hospital. Mr. Khuong holds a BS (Molecular Biology) and an MPH (Infectious Diseases) from Yale University.

Research Interest

Infectious Diseases